Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Johnson & Johnson ordered to pay pelvic mesh settlement of $344M

Johnson & Johnson has been ordered to pay $344 million to settle lawsuits that the pharmaceutical and consumer packaged goods deceptively marketed its transvaginal mesh medical device product.

Thumbnail

Purdue University invests $500K in AI startup

physIQ, an Indiana-based healthcare company using AI to track the physiological data of patients, has received a $500,000 investment from Purdue University’s Purdue Research Foundation.

Thumbnail

More than half of clinical studies fail to post results

Researchers conducting applicable clinical trials are required to post their study results within one year, but compliance with this requirement is very poor, according to a new study published in The Lancet.

Thumbnail

Why hospitals mergers fail to improve care

Healthcare mergers and acquisition has been on a hot streak for a number of years, but not all hospital mergers end up achieving their stated goals. For instance, hospital mergers may actually increase prices rather than decrease them, according to some studies.

Thumbnail

Coronavirus is a public health emergency

The World Health Organization has declared the novel coronavirus a public health emergency after more than 200 people have died from the illness.

Thumbnail

Will AI be a part of Trump’s State of the Union address?

President Trump is scheduled to deliver his State of the Union address on Tuesday, Feb. 4, at a time when most Americans have been focused on impeachment, the 2020 election and the coronavirus outbreak.

Thumbnail

Microsoft to launch $40M AI health initiative

Microsoft is launching a $40 million, five-year program that aims to leverage the company’s existing initiative and AI technology to help researchers and organizations tackle health challenges.

Thumbnail

Life expectancy rises as overdose deaths decline

For the first time in four years, U.S. life expectancy rose in 2018, according to new data from the CDC.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.